The Ghana Food and Drugs Authority (FDA) together with the National Medicine Regulatory Agency (NMRA) have approved a herbal medicine Cryptolepis Sanguinolenta locally known as Nibima for clinical trials for the treatment of Covid-19.
In a statement, the authority indicated that the approval of the herbal medicine comes on the back of laboratory studies conducted by the Kwame Nkrumah University of Science and Technology research team which proves the efficacy of the medicine against the virus.
WADR’s Atiewin Mbillah-Lawson has more in this report from Accra.
